Derivatives of phenylpropanoic acid substituted as alpha activated human proliferating peroxisome receptor (ppar) agonists

摘要

Invention Patent: "PHENYLPROPANOIC ACID DERIVATIVES REPLACED AS AGONISTS OF THE HUMAN ACTIVATED PROLIFERANT PEROXISOMA RECEPTOR (PPAR)". The invention provides new substituted phenylpropanoic acid derivatives that are activated by binding to a human activated proliferative peroxisome receptor (PPAR 244) ligand receptor and exhibit potent blood lipid lowering action (cholesterol and triglycerides). It refers to substituted phenylpropanoic acid derivatives represented by the general formula (1): their pharmaceutically acceptable salts and their hydrates and processes for preparing them.